Seres Therapeutics, Inc. (MCRB): Price and Financial Metrics
MCRB Price/Volume Stats
| Current price | $8.12 | 52-week high | $30.60 |
| Prev. close | $7.26 | 52-week low | $6.53 |
| Day low | $7.29 | Volume | 115,259 |
| Day high | $8.31 | Avg. volume | 84,116 |
| 50-day MA | $9.28 | Dividend yield | N/A |
| 200-day MA | $14.73 | Market Cap | 70.90M |
MCRB Stock Price Chart Interactive Chart >
Seres Therapeutics, Inc. (MCRB) Company Bio
Seres Therapeutics is a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. The company was founded in 2010 and is based in Cambridge, Massachusetts.
MCRB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MCRB Price Returns
| 1-mo | -2.05% |
| 3-mo | -46.96% |
| 6-mo | -50.69% |
| 1-year | -52.41% |
| 3-year | -90.24% |
| 5-year | -91.32% |
| YTD | -51.14% |
| 2024 | -40.64% |
| 2023 | -75.00% |
| 2022 | -32.77% |
| 2021 | -66.00% |
| 2020 | 610.14% |